281 related articles for article (PubMed ID: 21820670)
1. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.
Nohesara S; Ghadirivasfi M; Mostafavi S; Eskandari MR; Ahmadkhaniha H; Thiagalingam S; Abdolmaleky HM
J Psychiatr Res; 2011 Nov; 45(11):1432-8. PubMed ID: 21820670
[TBL] [Abstract][Full Text] [Related]
2. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.
Abdolmaleky HM; Nohesara S; Ghadirivasfi M; Lambert AW; Ahmadkhaniha H; Ozturk S; Wong CK; Shafa R; Mostafavi A; Thiagalingam S
Schizophr Res; 2014 Feb; 152(2-3):373-80. PubMed ID: 24411530
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.
Abdolmaleky HM; Cheng KH; Faraone SV; Wilcox M; Glatt SJ; Gao F; Smith CL; Shafa R; Aeali B; Carnevale J; Pan H; Papageorgis P; Ponte JF; Sivaraman V; Tsuang MT; Thiagalingam S
Hum Mol Genet; 2006 Nov; 15(21):3132-45. PubMed ID: 16984965
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder.
Ghadirivasfi M; Nohesara S; Ahmadkhaniha HR; Eskandari MR; Mostafavi S; Thiagalingam S; Abdolmaleky HM
Am J Med Genet B Neuropsychiatr Genet; 2011 Jul; 156B(5):536-45. PubMed ID: 21598376
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder.
Abdolmaleky HM; Pajouhanfar S; Faghankhani M; Joghataei MT; Mostafavi A; Thiagalingam S
Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):687-96. PubMed ID: 26285059
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase gene promoter methylation as a peripheral biomarker in male schizophrenia.
Gao S; Cheng J; Li G; Sun T; Xu Y; Wang Y; Du X; Xu G; Duan S
Eur Psychiatry; 2017 Jul; 44():39-46. PubMed ID: 28545007
[TBL] [Abstract][Full Text] [Related]
7. MB-COMT promoter DNA methylation is associated with working-memory processing in schizophrenia patients and healthy controls.
Walton E; Liu J; Hass J; White T; Scholz M; Roessner V; Gollub R; Calhoun VD; Ehrlich S
Epigenetics; 2014 Aug; 9(8):1101-7. PubMed ID: 24837210
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes.
Nohesara S; Ghadirivasfi M; Barati M; Ghasemzadeh MR; Narimani S; Mousavi-Behbahani Z; Joghataei M; Soleimani M; Taban M; Mehrabi S; Thiagalingam S; Abdolmaleky HM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1180-1189. PubMed ID: 27753212
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.
Abdolmaleky HM; Yaqubi S; Papageorgis P; Lambert AW; Ozturk S; Sivaraman V; Thiagalingam S
Schizophr Res; 2011 Jul; 129(2-3):183-90. PubMed ID: 21550210
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations of the dopaminergic system in major psychiatric disorders.
Abdolmaleky HM; Smith CL; Zhou JR; Thiagalingam S
Methods Mol Biol; 2008; 448():187-212. PubMed ID: 18370235
[TBL] [Abstract][Full Text] [Related]
11. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia.
Murphy BC; O'Reilly RL; Singh SM
Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):37-42. PubMed ID: 15635661
[TBL] [Abstract][Full Text] [Related]
12. Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.
Abdolmaleky HM; Gower AC; Wong CK; Cox JW; Zhang X; Thiagalingam A; Shafa R; Sivaraman V; Zhou JR; Thiagalingam S
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):138-149. PubMed ID: 30468562
[TBL] [Abstract][Full Text] [Related]
13. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder.
Carrard A; Salzmann A; Malafosse A; Karege F
J Affect Disord; 2011 Aug; 132(3):450-3. PubMed ID: 21453976
[TBL] [Abstract][Full Text] [Related]
14. The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression.
Dempster EL; Mill J; Craig IW; Collier DA
BMC Med Genet; 2006 Feb; 7():10. PubMed ID: 16483362
[TBL] [Abstract][Full Text] [Related]
15. The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia.
Lott SA; Burghardt PR; Burghardt KJ; Bly MJ; Grove TB; Ellingrod VL
Pharmacogenomics J; 2013 Jun; 13(3):264-71. PubMed ID: 22391769
[TBL] [Abstract][Full Text] [Related]
16. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation in peripheral tissue of schizophrenia and bipolar disorder: a systematic review.
Teroganova N; Girshkin L; Suter CM; Green MJ
BMC Genet; 2016 Jan; 17():27. PubMed ID: 26809779
[TBL] [Abstract][Full Text] [Related]
18. Personality in relation to genetic liability for schizophrenia and bipolar disorder: differential associations with the COMT Val 108/158 Met polymorphism.
Silberschmidt AL; Sponheim SR
Schizophr Res; 2008 Mar; 100(1-3):316-24. PubMed ID: 18201871
[TBL] [Abstract][Full Text] [Related]
19. Manic symptom severity correlates with COMT activity in the striatum: A post-mortem study.
Bortolato M; Walss-Bass C; Thompson PM; Moskovitz J
World J Biol Psychiatry; 2017 Apr; 18(3):247-254. PubMed ID: 27458023
[TBL] [Abstract][Full Text] [Related]
20. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder.
Dempster EL; Pidsley R; Schalkwyk LC; Owens S; Georgiades A; Kane F; Kalidindi S; Picchioni M; Kravariti E; Toulopoulou T; Murray RM; Mill J
Hum Mol Genet; 2011 Dec; 20(24):4786-96. PubMed ID: 21908516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
